Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
US FDA Needs ‘More Streamlined’ REMS Enforcement Authority, Inspector General Says
Sep 30 2020
•
By
Derrick Gingery
The HHS OIG also called for mandated opioid prescriber training through the REMS, but the FDA disagreed. • Source: Shutterstock
More from Drug Safety
More from Pink Sheet